Karen S. Mark

2.2k total citations
19 papers, 1.8k citations indexed

About

Karen S. Mark is a scholar working on Neurology, Molecular Biology and Oncology. According to data from OpenAlex, Karen S. Mark has authored 19 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Neurology, 6 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Karen S. Mark's work include Barrier Structure and Function Studies (13 papers), Neurological Disease Mechanisms and Treatments (6 papers) and Drug Transport and Resistance Mechanisms (4 papers). Karen S. Mark is often cited by papers focused on Barrier Structure and Function Studies (13 papers), Neurological Disease Mechanisms and Treatments (6 papers) and Drug Transport and Resistance Mechanisms (4 papers). Karen S. Mark collaborates with scholars based in United States. Karen S. Mark's co-authors include Thomas P. Davis, Donald W. Miller, K. Witt, Jason D. Huber, William J. Trickler, Sharon Hom, Richard D. Egleton, Rachel C. Brown, Brian T. Hawkins and Thomas J. Abbruscato and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Cell Science and Journal of Neurochemistry.

In The Last Decade

Karen S. Mark

18 papers receiving 1.8k citations

Peers

Countries citing papers authored by Karen S. Mark

Since Specialization

Citations

This map shows the geographic impact of Karen S. Mark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen S. Mark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen S. Mark more than expected).

Fields of papers citing papers by Karen S. Mark

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen S. Mark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen S. Mark. The network helps show where Karen S. Mark may publish in the future.

Co-authorship network of co-authors of Karen S. Mark

This figure shows the co-authorship network connecting the top 25 collaborators of Karen S. Mark. A scholar is included among the top collaborators of Karen S. Mark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen S. Mark. Karen S. Mark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	PP451 Does NICE Reimburse Oncology Treatments Meeting End-Of-Life Criteria More Often Than Treatments That Do Not? 2021 ·International Journal of Technology Assessment in Health Care ·(unknown), Karen S. Mark, (unknown)	0
2	Implementation, Revisions, and Student Perceptions of a Pre-Matriculation Program in a School of Pharmacy 2019 ·American Journal of Pharmaceutical Education ·Eytan A. Klausner, (unknown), (unknown), Karen S. Mark	9
3	α1-Acid glycoprotein induced effects in rat brain microvessel endothelial cells 2012 ·Microvascular Research ·Shuangling Zhang, Karen S. Mark	19
4	Reoxygenation stress on blood–brain barrier paracellular permeability and edema in the rat 2007 ·Microvascular Research ·K. Witt, Karen S. Mark, Karin E. Sandoval, Thomas P. Davis	56
5	Alterations in blood-brain barrier ICAM-1 expression and brain microglial activation after λ-carrageenan-induced inflammatory pain 2005 ·American Journal of Physiology-Heart and Circulatory Physiology ·Jason D. Huber, Christopher Campos, Karen S. Mark, Thomas P. Davis	85
6	Hypoxia‐inducible factor and nuclear factor kappa‐B activation in blood–brain barrier endothelium under hypoxic/reoxygenation stress 2004 ·Journal of Neurochemistry ·K. Witt, Karen S. Mark, Jason D. Huber, Thomas P. Davis	45
7	Nitric oxide mediates hypoxia-induced changes in paracellular permeability of cerebral microvasculature 2004 ·American Journal of Physiology-Heart and Circulatory Physiology ·Karen S. Mark, (unknown), Rachel C. Brown, Jason D. Huber, Thomas P. Davis	45
8	Protection against hypoxia-induced blood-brain barrier disruption: changes in intracellular calcium 2004 ·American Journal of Physiology-Cell Physiology ·Rachel C. Brown, Karen S. Mark, Richard D. Egleton, Thomas P. Davis	49
9	Effects of hypoxia-reoxygenation on rat blood-brain barrier permeability and tight junctional protein expression 2003 ·American Journal of Physiology-Heart and Circulatory Physiology ·K. Witt, Karen S. Mark, Sharon Hom, Thomas P. Davis	163
10	Protection against hypoxia-induced increase in blood-brain barrier permeability: role of tight junction proteins and NFκB 2003 ·Journal of Cell Science ·Rachel C. Brown, Karen S. Mark, Richard D. Egleton, Jason D. Huber, (unknown), Thomas P. Davis	85
11	Nicotine and Cotinine Modulate Cerebral Microvascular Permeability and Protein Expression of ZO-1 through Nicotinic Acetylcholine Receptors Expressed on Brain Endothelial Cells 2002 ·Journal of Pharmaceutical Sciences ·Thomas J. Abbruscato, (unknown), Karen S. Mark, Brian T. Hawkins, Thomas P. Davis	148
12	Viability of microvascular endothelial cells to direct exposure of formalin, λ-carrageenan, and complete Freund's adjuvant 2002 ·European Journal of Pharmacology ·Jason D. Huber, Vincent Hau, Karen S. Mark, Rachel C. Brown, (unknown), Thomas P. Davis	10
13	Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation 2002 ·American Journal of Physiology-Heart and Circulatory Physiology ·Karen S. Mark, Thomas P. Davis	326
14	Tumor Necrosis Factor-α Induces Cyclooxygenase-2 Expression and Prostaglandin Release in Brain Microvessel Endothelial Cells 2001 ·Journal of Pharmacology and Experimental Therapeutics ·Karen S. Mark, William J. Trickler, Donald W. Miller	74
15	Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression 2001 ·American Journal of Physiology-Heart and Circulatory Physiology ·Jason D. Huber, K. Witt, Sharon Hom, Richard D. Egleton, Karen S. Mark, Thomas P. Davis	221
16	Tumor necrosis factor-alpha induces cyclooxygenase-2 expression and prostaglandin release in brain microvessel endothelial cells. 2001 ·PubMed ·Karen S. Mark, William J. Trickler, Donald W. Miller	159
17	Stroke: development, prevention and treatment with peptidase inhibitors☆ 2000 ·Peptides ·Karen S. Mark, Thomas P. Davis	32
18	Increased permeability of primary cultured brain microvessel endothelial cell monolayers following TNF-α exposure 1999 ·Life Sciences ·Karen S. Mark, Donald W. Miller	117
19	Expression of Multidrug Resistance-Associated Protein (MRP) in Brain Microvessel Endothelial Cells 1998 ·Biochemical and Biophysical Research Communications ·(unknown), (unknown), Karen S. Mark, (unknown), (unknown), William F. Elmquist, Donald W. Miller	169

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact